“…These stem cells are capable of differentiating into various cellular lineages, including the osteogenic, chondrogenic, adipogenic, and myogenic lineages (Pittenger et al, 1999;Jiang et al, 2002;Imabayashi et al, 2003;Bosch et al, 2006), and are widely used in clinical investigations (Friedenstein et al, 1966;Horwitz et al, 2002;Kadivar et al, 2006;Yang et al, 2008). Before human clinical trials can be approved, scaled-up cell production and delivery into an animal model with cell doses (number of cells) comparable to those anticipated for human trials are often required in order to satisfy regulatory safety concerns.…”